Age of the bone marrow dictates clonality of smooth muscle-derived cells in the atherosclerotic plaque
I. Kabir, X. Zhang, J. Dave, R. Chakraborty, R. Qu, R. R. Chandran, A. Ntokou, E. Gallardo-Vara, B. Aryal, N. Rotllan, R. Garcia-Milian, J. Hwa, Y. Klugar, K. A. Martin, C. Fernandez-Hernando, D. M. Greif
Abstract
Aging is the predominant risk factor for atherosclerosis, the leading cause of death. Rare smooth muscle cell (SMC) progenitors clonally expand giving rise to up to [~]70% of atherosclerotic plaque cells; however, the effect of age on SMC clonality is not known. Our results indicate that aged bone marrow (BM)-derived cells non-cell autonomously induce SMC polyclonality and worsen atherosclerosis. Indeed, in myeloid cells from aged mice and humans, TET2 levels are reduced which epigenetically silences integrin {beta}3 resulting in increased tumor necrosis factor [TNF]- signaling. In turn, TNF signals through TNF receptor 1 on SMCs to promote proliferation and induces recruitment and expansion of multiple SMC progenitors into the atherosclerotic plaque. Notably, integrin {beta}3 overexpression in aged BM preserves dominance of the lineage of a single SMC progenitor and attenuates plaque burden. Our results demonstrate a molecular mechanism of aged macrophage-induced SMC polyclonality and atherogenesis and suggest novel therapeutic strategies. Graphical abstractAge of BM-derived monocytes/macrophages determines clonality of SMC lineage in the atherosclerotic plaque. Atherogenesis is depicted in a young (a) or aged (b) host. Aged monocytes/macrophages have decreased levels of the epigenetic regulator TET2, leading to reduction of the 5-hydroxymethylcytosine (5hmC) mark on the Itgb3 promoter. The resulting low integrin {beta}3 levels in aged monocytes/macrophages induces high TNF- levels, facilitating recruitment and expansion of multiple SMC progenitors (polyclonality) in the atherosclerotic plaque and worse disease burden. In contrast, the young control is characterized by mono/oligoclonal SMC expansion in a smaller plaque. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=135 SRC="FIGDIR/small/476756v2_ufig1.gif" ALT="Figure 1"> View larger version (28K): org.highwire.dtl.DTLVardef@12f7090org.highwire.dtl.DTLVardef@186ff92org.highwire.dtl.DTLVardef@1f4da69org.highwire.dtl.DTLVardef@2f509c_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Increased expression of Cd74 and MHC II genes by aortic macrophages links atherosclerosis with aging in mice
Adyasha Mishra, Inderjit S Dhami, … Pijus Kanti Barman·bioRxiv·Jul 21, 2026
- Conditional deletion of Ccl2 in smooth muscle cells does not reduce early atherosclerosis in mice
S. Gunnersen, J. T. Shim, … J. F. Bentzon·bioRxiv·Aug 6, 2023
- Treatment of advanced atherosclerotic mice with the senolytic agent ABT-263 is associated with reduced indices of plaque stability and increased mortality
S. Karnewar, V. Karnewar, … G. K. Owens·bioRxiv·Jul 12, 2023
- Atherosclerosis is a smooth muscle cell-driven tumor-like disease
H. Pan, S. E. Ho, … M. P. Reilly·bioRxiv·Mar 6, 2023
- Macrophage-like vascular smooth muscle cells dominate early atherosclerosis and are inhibited by targeting iron regulation
Rijan Gurung, Chang Jie Mick Lee, … Roger Foo·bioRxiv·May 22, 2025
- The environment-sensing aryl-hydrocarbon receptor inhibits the chondrogenic fate of modulated smooth muscle cells in atherosclerotic lesions
Juyong Brian Kim, Quanyi Zhao, … Thomas Quertermous·CirculationPeer-reviewed·May 22, 2020